Loading company…
WittGen develops profiling technology for clinical development and oncology patient stratification.
WittGen develops Virtual Cell-to-Patient profiling technology for patient stratification in oncology research. Its platform analyzes archived bulk RNA samples and pathological image data for pharmaceutical companies and academic institutions. Founded in 2023 and based in Berkeley, US, it received undisclosed funding in May 2026 from Digital Healthcare Partners, with participation from returning investor Nautilus Investment.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in